Getting an Extra Dose Out of Your Mounjaro Pen: What You Need to Know

Each Mounjaro KwikPen contains four pre-set weekly doses — not five, and not a spare partial dose at the end.
The pen is engineered with a small amount of overfill to ensure each of the four doses is complete; that residual liquid is not an additional therapeutic dose.
Attempting to extract more than four doses risks inaccurate dosing, needle contamination, and wasted medicine, and is outside the pen's licensed use.
If you have missed a dose or are unsure how much medicine remains, your prescriber and the Patient Information Leaflet are the right sources of guidance, not the pen's plunger position.

Each Mounjaro KwikPen is designed to deliver exactly four weekly doses of tirzepatide. You cannot safely extract an extra dose from a pen that has reached its final injection, and attempting to do so risks an inaccurate amount of medicine, a contaminated needle, or no medicine at all. Here is what the device actually contains, why the question arises, and what to do instead — all based on the pen's licensed design. Like all prescription-only medicines, Mounjaro must be prescribed following a clinical assessment; a prescriber decides the dose that is right for you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The detail behind the device: doses, overfill, and what to do at the end of your pen

Why do people think there is a fifth dose in the pen?

A question our prescribers hear most weeks goes something like this: "There's still a bit of liquid left after my fourth injection, can I use it?" It is a completely understandable thing to notice. When you deliver the fourth dose and remove the pen, a small amount of liquid remains visible in the cartridge. The pen does not feel empty.

That residual liquid is overfill, deliberately included by Eli Lilly during manufacture to guarantee that each of the four labelled doses is complete and accurate. Medical device regulators expect injectable pens to carry this buffer; it is standard practice, not a bonus supply. The Mounjaro SmPC on the eMC confirms the pen delivers four doses; nothing in the licensed documentation describes a fifth. The overfill is not in a usable, measurable, sterile state once the four doses have been drawn down through the pen's mechanism.

Beyond the residual-liquid question, some people try to draw a fifth dose by attaching a fresh needle and pressing the plunger manually, and if you are curious about getting an extra dose out of Mounjaro this way, it is worth understanding why the approach does not work. The KwikPen's auto-injection mechanism is not designed for this. You are unlikely to get a consistent volume, you risk introducing contamination through repeated needle attachment, and the plunger stop exists for a reason. The result would be an unknown quantity of medicine, not a clinically meaningful dose of tirzepatide.

Does the amount of liquid in the cartridge tell you how many doses are left?

Not reliably, no. The cartridge is not a graduated measuring vessel. Liquid levels shift depending on how the pen is stored (lying flat versus upright), temperature, and whether air bubbles are present. Judging remaining doses by the fluid line is the kind of shortcut that looks logical but is not accurate enough for a prescription medicine.

The safer habit is to count your injections. Each pen delivers four weekly doses. If you started a new pen four weeks ago, it is finished. Some people keep a simple record on their phone or mark the date of the first injection on the pen itself with a marker, small practical steps that remove the guesswork entirely. Our Mounjaro dosage guide walks through the titration schedule and how to track where you are in your treatment.

Storage conditions matter here too. Mounjaro pens should be kept refrigerated at 2–8°C. A pen that has been stored outside those conditions, or carried at room temperature beyond the window stated in the Patient Information Leaflet, may not deliver medicine that is still fully effective, another reason liquid appearance alone tells you very little. For exact storage guidance, the leaflet inside your pen box is the authoritative source. It is also worth knowing that if your Mounjaro pen appears to have an extra dose based on the fluid level, that appearance is explained by the overfill buffer rather than any additional supply.

What should you do when your pen runs out before your next supply arrives?

This is the practical problem behind most "extra dose" searches. The pen is done, the next one has not arrived, and the weekly injection window is approaching. There are a few options worth knowing.

First, a short delay of a day or two is unlikely to be clinically significant for most people, but you should confirm this with your prescriber rather than assume it. The NHS medicines guidance for tirzepatide, available at nhs.uk/medicines/tirzepatide, notes that missed dose advice should come from your healthcare team. Do not attempt to extend the pen.

Second, plan supply so that a gap does not arise. At nume, orders placed before 12pm on a working day are reviewed by a GPhC-registered prescriber and, if clinically suitable, dispatched the same afternoon by DPD for next-working-day delivery. That predictable turnaround means you can time your repeat order so the next pen arrives before the current one finishes. If you are transferring from another provider or have a supply question, our team is reachable through our contact page.

Third, if you are wondering whether a different dose strength or a change in your schedule would suit you better, that is a conversation for your prescriber at your next clinical review, not a problem to solve by rationing individual pens. For a broader look at how Mounjaro fits into a weight-management plan, our treatment overview covers the context.

Is trying to get more from the pen a safety risk?

In practical terms, yes, though not a dramatic one. The risks are not exotic. Attaching a fresh needle to a pen that has delivered its four doses and attempting a manual injection may result in: no medicine being delivered (so you miss your dose entirely); an air-shot that introduces bubbles to the injection site; or a very small, inconsistent volume that does not represent a therapeutic amount of tirzepatide at any licensed dose strength. Our page on Mounjaro extra dose explains in more detail why none of these outcomes constitute a real additional dose.

None of these outcomes are helpful. The more significant risk is the knock-on effect: if you believe you have taken a dose and have not, your appetite suppression and blood-glucose response will be absent that week, without you realising why. That uncertainty is worth avoiding. Some users also ask whether you can get 5 doses out of a Mounjaro pen, and the answer, for all the reasons above, is no. Tirzepatide is a dual GIP and GLP-1 receptor agonist whose effect depends on consistent weekly dosing; consistency matters more than squeezing the last drop from a cartridge.

If you have questions about your current pen, a dose you may have missed, or what to expect at your next titration step, the right route is your prescriber or the Patient Information Leaflet. You can also review common questions on our FAQ page. For those who have not yet started treatment and want to understand whether Mounjaro is clinically appropriate for them, starting a free consultation is the place to begin.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions